Oramed Pharmaceuticals Inc. — Director's Dealing 2017

Aug 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2017-08-02

Reporting Person: Kidron Miriam (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-02	Common Stock	S	89636	$8.5	Disposed	75000	Direct

Footnotes

F1: These shares were sold to Li Xiaopeng, a director of Oramed Pharmaceuticals Inc., and the reporting person used the proceeds in connection with a personal tax payment.

F2: Consists of 75,000 shares of Common Stock underlying vested Restricted Stock Units that are issuable upon request.